Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program. J of Skin [Internet]. 2025 Jul. 23 [cited 2025 Nov. 16];9(4):s583. Available from: https://skin.dermsquared.com/skin/article/view/3493